Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-14

Clinical Trial Update: Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients

View source ↗

Summary

Completed study assessing the relationship between serum infliximab levels and efficacy in patients with luminal Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: University of Western Ontario, Canada | Conditions: Crohn's Disease | Status: COMPLETED